-
Children health
0.91
-
Children health
0.84
Adriana Lourenço Da SILVA; Hoffmann A; Marcelo DIETRICH; Oscar Dall IGNA; Diogo O SOUZA et al.
2010.
Effect of riluzole on mk801 and amphetamine-induced hyperlocomotion.
Neuropsychobiology.
48,
(1)
27-30.
-
Children health
0.91
-
Children health
0.93
André P SCHMIDT; A B TORT; Pp SILVEIRA; Ana Elisa BÖHMER; G HANSEL et al.
2009.
The nmda antagonist mk-801 induces hyperalgesia and increases csf excitatory amino acids in rats: reversal by guanosine.
Pharmacology; biochemistry and behavior.
91,
549-553.
-
Children health
0.93
André P SCHMIDT; Ana Elisa BÖHMER; Catiele ANTUNES; C SCHALLENBERGER; Lisiane O PORCIUNCULA et al.
2009.
Anti-nociceptive properties of the xanthine oxidase inhibitor allopurinol in mice: role of a1 adenosine receptors.
British journal of pharmacology.
156,
163-172.
-
Children health
0.96
Rodrigo Machado VIEIRA; Jair C SOARES; Diogo Rizzato LARA; David A LUCKENBAUGH; Joao V BUSNELLO et al.
2008.
A double-blind; randomized; placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania.
Journal of clinical psychiatry.
69,
1237-1245.
-
Children health
0.80
André P SCHMIDT; A B TORT; Diogo Rizzato LARA; Diogo O SOUZA.
2008.
Guanosine and its modulatory effects on the glutamatergic system.
European neuropsychopharmacology.
18,
620-622.
-
Children health
0.93
Op Dall IGNA; Paulo FETT; Marcio W GOMES; Rodrigo A CUNHA; Diogo O SOUZA et al.
2007.
Caffeine and adenosine a2a receptor antagonists prevent beta-amyloid(25-35)-induced cognitive deficits in mice.
Experimental neurology.
203,
241-245.
-
Children health
0.74
A P SCHMIDT; Diogo Rizzato LARA; Diogo O SOUZA.
2007.
Proposal of a guanine-based purinergic system in the mammalian central nervous system.
Pharmacology & therapeutics (oxford).
116,
401-416.
-
Children health
0.89
A B TORT; Do SOUZA; Diogo Rizzato LARA.
2006.
Theoretical insights on the mechanism of action of atypical antipsychotics.
Progress in neuropsychopharmacology and biological psychiatry.
30,
541-548.
-
Children health
0.92
Diogo Rizzato LARA; Rodrigo GRILLO; Gustavo OTTONI; Renata LEKE; Do SOUZA et al.
2006.
Reduced serum bdnf levels in schizophrenic patients on clozapine or typical antipsychotics.
Journal of psychiatric research.
Estados Unidos.
-.
-
Children health
0.70
A B TORT; Ricardo Vígolo De OLIVEIRA; Juliana SCHUH; Diogo O SOUZA; Diogo Rizzato LARA.
2005.
Atypical antipsychotic profile of flunarizine in animal models.
Psychopharmacology.
177,
344-348.
-
Children health
0.91
Da Silva RS; A HOFFMANN; Diogo O SOUZA; Diogo Rizzato LARA; Cd BONAN.
2005.
Maternal caffeine intake impairs mk-801-induced hyperlocomotion in young rats.
European journal of pharmacology.
Estados Unidos.
509,
155-159.
-
Children health
0.93
Ricardo Vígolo De OLIVEIRA; A B TORT; Op Dall IGNA; Jf SCHUH; Pf NETO et al.
2005.
Effect of subchronic caffeine treatment on mk-801-induced changes in locomotion; cognition and ataxia in mice.
Behavioural pharmacology.
Inglaterra.
16,
79-84.
-
Children health
0.87
A B TORT; Do SOUZA; Diogo Rizzato LARA.
2005.
Half the dose of antipsychotic in case of extrapyramidal symptoms.
Schizophrenia research.
Estados Unidos.
78,
347-349.
-
Children health
0.92
-
Children health
0.87
-
Children health
0.87
Op Dall IGNA; Diogo O SOUZA; Diogo Rizzato LARA.
2004.
Caffeine as a neuroprotective adenosine receptor antagonist.
Annals of pharmacotherapy.
Estados Unidos.
38,
717-718.
-
Children health
0.92
Elsa R VINADE; Ivan IZQUIERDO; Diogo Rizzato LARA; A P SCHMIDT; Diogo O SOUZA.
2004.
Oral administration of guanosine impairs inhibitory avoidance performance in rats and mice.
Neurobiology of learning and memory.
Estados Unidos.
81,
137-143.
-
Children health
0.91
Diogo Rizzato LARA; A B TORT; Op Dall IGNA; Diogo O SOUZA.
2004.
Guanosine selectively inhibits locomotor stimulation induced by the nmda antagonist dizocilpine.
Behavioural brain research.
Estados Unidos.
-.
-
Children health
0.90
A B TORT; Diogo O SOUZA; Diogo Rizzato LARA.
2004.
On the simulation of the time-course of dopamine d2 receptors occupancy from the pharmacokinetics of antipsychotics.
International journal of neuropsychopharmacology.
Estados Unidos.
8,
137-139.
-
Children health
0.90
Jean P OSES; Renata LEKE; L V PORTELA; Diogo Rizzato LARA; A P SCHMIDT et al.
2004.
Biochemical brain markers and purinergic parameters in rat csf after seizure induced by pentylenetetrazol.
Brain research bulletin.
Estados Unidos.
64,
237-242.
-
Children health
0.92
Mo DIETRICH; L ROTTA; Diogo O SOUZA; C PERRY; C MANTESE et al.
2004.
Increased locomotor response to amphetamine; but not other psychostimulants; in adult mice submitted to a low protein diet.
Physiology and behavior.
Estados Unidos.
83,
129-133.
-
Children health
0.91
-
Children health
0.89
Diogo Rizzato LARA; Matheus R S CRUZ; Do SOUZA; Flávio XAVIER; Emilio H MORIGUCHI.
2003.
Allopurinol for the treatment of aggressive behaviour in patients with dementia.
International clinical psychopharmacology.
Grã-Bretanha.
18,
53-55.
-
Children health
0.92
Op Dall IGNA; Adriana Lourenço Da SILVA; Mo DIETRICH; A HOFFMANN; Ricardo Vígolo De OLIVEIRA et al.
2003.
Chronic treatment with caffeine blunts the hyperlocomotor but no cognitive effect of the nmda receptor antagonist mk-801 in mice.
Psychopharmacology.
Alemanha.
166,
258-263.
-
Children health
0.89
Rosane SALVI; Diogo Rizzato LARA; Eduardo S GHISOLFI; L V PORTELA; Renato D DIAS et al.
2003.
Neuropsychiatric evaluation in subjects chronically exposed to organophosphate pesticides.
Toxicological science.
Estados Unidos.
72,
267-271.
-
Children health
0.87
Rodrigo Machado VIEIRA; Diogo Rizzato LARA; Diogo O SOUZA; F KAPCZINSKI.
2002.
Purinergic dysfunction in mania: an integrative model.
Medical hypotheses.
Inglaterra.
58,
297-304.
-
Children health
0.90
Eduardo S GHISOLFI; Alexandre S PROKOPIUK; Jefferson BECKER; João Arthur EHLERS; Paulo Belmonte De ABREU et al.
2002.
The adenosine antagonist theophylline impairs p50 auditory sensory gating in normal subjects.
Neuropsychopharmacology (new york).
27,
(4)
629-637.
-
Children health
0.89
L V PORTELA; Jean P OSES; A L SILVEIRA; André P SCHMIDT; Diogo Rizzato LARA et al.
2002.
Guanine and adenine nucleotidase activities in rat cerebrospinal fluid.
Brain research.
Estados Unidos.
950,
74-78.
-
Children health
0.92
Marcos E S FRIZZO; Diogo Rizzato LARA; Alexandre S PROKOPIUK; C R VARGAS; C SALBEGO et al.
2002.
Guanosine enhances glutamate uptake in brain cortical slices at normal and excitotoxic conditions.
Cellular and molecular neurobiology.
Estados Unidos.
22,
353-363.
-
Children health
0.93
A S COITINHO; Mo DIETRICH; A HOFFMANN; Op Dall IGNA; Do SOUZA et al.
2002.
Decreased hyperlocomotion induced by mk-801; but not amphetamine and caffeine in mice lacking cellular prion protein (prpc).
Molecular brain research.
Estados Unidos.
170,
190-194.
-
Children health
0.91
Diogo Rizzato LARA; Clarissa Severino GAMA; Paulo Belmonte De ABREU; L V PORTELA; Carlos Alberto GONÇALVES et al.
2001.
Increased serum s100b protein in schizophrenia: a study in medication-free patients.
Journal of psychiatric research.
Estados Unidos.
35,
11-14.
-
Children health
0.90
Marcos E S FRIZZO; Diogo Rizzato LARA; Kelly C S DAHM; Alexandre S PROKOPIUK; Raymond SWANSON et al.
2001.
Activation of glutamate uptake by guanosine in primary astrocyte culture.
Neuroreport (oxford).
Inglaterra.
12,
879-881.
-
Public administration
0.42
Diogo Rizzato LARA; Diogo O SOUZA.
2001.
Modelo de hipofunção adenosinérgica em esquizofrenia: interação entre os sistemas purinérgico; glutamatérgico e dopaminérgico.
Revista de psiquiatria clínica.
Brasil.
28,
(3)
160-169.
-
Children health
0.92
Miriam G BRUNSTEIN; Paulo Belmonte De ABREU; Diogo O SOUZA; Diogo Rizzato LARA.
2001.
Therapeutic benefit of adjunctive dipyridamole in schizophrenia is probably due to adenosine-glutamate interactions.
Journal of clinical pharmacy and therapeutics.
Inglaterra.
26,
155-156.
-
Children health
0.84
Diogo Rizzato LARA; Ellis D Arrigo BUSNELLO; Diogo O SOUZA.
2001.
Ondansetron rather than metoclopramide for bupropion-induced nausea.
Canadian journal of psychiatry.
Canadá.
46,
371-371.
-
Children health
0.92
Diogo Rizzato LARA; A P SCHMIDT; Marcos E S FRIZZO; Galo RAMIREZ; Javier BURGOS et al.
2001.
Effect of orally administered guanosine on seizures and death induced by glutamatergic agents.
Brain research.
Estados Unidos.
912,
(2)
176-180.
-
Children health
0.73
Diogo Rizzato LARA; Diogo O SOUZA.
2001.
Should we keep calling antidepressants antidepressants?.
Journal of clinical psychiatry.
Estados Unidos.
62,
829-830.
-
Children health
0.87
Op Dall IGNA; Mo DIETRICH; A HOFFMANN; W NETO; Da VENDITE et al.
2001.
Catalepsy and hypolocomotion induced by a nitric oxide donor: attenuation by theophylline.
European journal of pharmacology.
Inglaterra.
432,
29-33.
-
Children health
0.80
Diogo Rizzato LARA; Diogo O SOUZA.
2000.
Schizophrenia: a purinergic hypothesis.
Medical hypotheses.
Inglaterra.
54,
157-166.
-
Children health
0.84
Diogo Rizzato LARA; Diogo O SOUZA.
2000.
Adenosine and antidepressant effects of sleep deprivation.
American journal of psychiatry.
Estados Unidos.
157,
1707-1708.
-
Children health
0.90
A P SCHMIDT; Diogo Rizzato LARA; J F MARASCHIN; A S PERLA; Diogo O SOUZA.
2000.
Guanosine and gmp prevent seizures induced by quinolinic acid in mice.
Brain research.
Estados Unidos.
864,
40-43.
-
Children health
0.89
Rafael ROESLER; Monica R VIANNA; Diogo Rizzato LARA; Ivan IZQUIERDO; André P SCHMIDT et al.
2000.
Guanosine impairs inhibitory avoidance performance in rats.
Neuroreport (oxford).
Inglaterra.
11,
(11)
2537-2540.